These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37349822)

  • 1. HPV self-sampling versus healthcare provider collection on the effect of cervical cancer screening uptake and costs in LMIC: a systematic review and meta-analysis.
    Mekuria SF; Timmermans S; Borgfeldt C; Jerkeman M; Johansson P; Linde DS
    Syst Rev; 2023 Jun; 12(1):103. PubMed ID: 37349822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis.
    Yeh PT; Kennedy CE; de Vuyst H; Narasimhan M
    BMJ Glob Health; 2019; 4(3):e001351. PubMed ID: 31179035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions to increase the uptake of cervical cancer screening in low- and middle-income countries: a systematic review and meta-analysis.
    Tin KN; Ngamjarus C; Rattanakanokchai S; Sothornwit J; Aue-Aungkul A; Paing AK; Pattanittum P; Jampathong N; Lumbiganon P
    BMC Womens Health; 2023 Mar; 23(1):120. PubMed ID: 36959632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing high risk HPV-based primary screening for cervical cancer in low- and middle-income countries: opportunities and challenges.
    Pimple SA; Mishra GA
    Minerva Ginecol; 2019 Oct; 71(5):365-371. PubMed ID: 31698891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does self-sampling for human papilloma virus testing have the potential to increase cervical cancer screening? An updated meta-analysis of observational studies and randomized clinical trials.
    Di Gennaro G; Licata F; Trovato A; Bianco A
    Front Public Health; 2022; 10():1003461. PubMed ID: 36568753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards the elimination of cervical cancer in low-income and lower-middle-income countries: modelled evaluation of the effectiveness and cost-effectiveness of point-of-care HPV self-collected screening and treatment in Papua New Guinea.
    Nguyen DTN; Simms KT; Keane A; Mola G; Bolnga JW; Kuk J; Toliman PJ; Badman SG; Saville M; Kaldor J; Vallely A; Canfell K
    BMJ Glob Health; 2022 Mar; 7(3):. PubMed ID: 35241461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of cervical cancer education and provider recommendation for screening on screening rates: A systematic review and meta-analysis.
    Musa J; Achenbach CJ; O'Dwyer LC; Evans CT; McHugh M; Hou L; Simon MA; Murphy RL; Jordan N
    PLoS One; 2017; 12(9):e0183924. PubMed ID: 28873092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Papilloma Virus self-sampling performance in low- and middle-income countries.
    Kamath Mulki A; Withers M
    BMC Womens Health; 2021 Jan; 21(1):12. PubMed ID: 33407355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.
    Tesfahunei HA; Ghebreyesus MS; Assefa DG; Zeleke ED; Acam J; Joseph M; Getachew E; Kajogoo VD; Bekele D; Manyazewal T
    Infect Agent Cancer; 2021 Jun; 16(1):43. PubMed ID: 34147103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Influencing the Cost-Effectiveness Outcomes of HPV Vaccination and Screening Interventions in Low-to-Middle-Income Countries (LMICs): A Systematic Review.
    Okeah BO; Ridyard CH
    Appl Health Econ Health Policy; 2020 Oct; 18(5):641-654. PubMed ID: 32468410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial.
    Gizaw M; Teka B; Ruddies F; Abebe T; Kaufmann AM; Worku A; Wienke A; Jemal A; Addissie A; Kantelhardt EJ
    Cancer Prev Res (Phila); 2019 Sep; 12(9):609-616. PubMed ID: 31337647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of HPV testing on self-collected and clinician-collected samples for different screening strategies in African settings: A systematic review and meta-analysis.
    Sy F; Greuel M; Winkler V; Bussmann H; Bärnighausen T; Deckert A
    Gynecol Oncol; 2022 Aug; 166(2):358-368. PubMed ID: 35781165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
    Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
    Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of cervical cancer screening methods in low- and middle-income countries: A systematic review.
    Mezei AK; Armstrong HL; Pedersen HN; Campos NG; Mitchell SM; Sekikubo M; Byamugisha JK; Kim JJ; Bryan S; Ogilvie GS
    Int J Cancer; 2017 Aug; 141(3):437-446. PubMed ID: 28297074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review and meta-analysis of diagnostic accuracy of HPV tests for the screening of cervical cancer in low-resource settings.
    Magdi R; Elshafeey F; Elshebiny M; Kamel M; Abuelnaga Y; Ghonim M; Nabhan A;
    Int J Gynaecol Obstet; 2021 Jan; 152(1):12-18. PubMed ID: 33124048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acting on the call for cervical cancer elimination: Planning tools for low- and middle- income countries to increase the coverage and effectiveness of screening and treatment.
    Herrick T; Thomson KA; Shin M; Gannon S; Tsu V; de Sanjosé S
    BMC Health Serv Res; 2022 Oct; 22(1):1246. PubMed ID: 36241993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol of the ACCESS trial: a randomised trial to evaluate the effectiveness of human papillomavirus testing by self-sampling in cervical cancer screening uptake and precancer detection.
    Fujita M; Shimazu M; Nagashima K; Suzuki M; Tauchi I; Sakuma M; Yamamoto S; Shozu M; Hanaoka H; Tsuruoka N; Kasai T; Hata A
    BMJ Open; 2022 Feb; 12(2):e049803. PubMed ID: 35115348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.